Suchergebnisse - "Bromodomain and extra-terminal domain protein, human"

PubPharm (242)

1

RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma

enthalten in: Scientific reports | 2024

von Jermakowicz, A. | Kurimchak, A. | Johnson, K. | +9

2

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Rossi, T. | Zamponi, R. | Chirico, M. | +6

3

BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes

enthalten in: Blood | 2022

von Zaiken, M. | Flynn, R. | Paz, K. | +29

CommentIn: Blood. 2022 May 12;139(19):2853-2854. - PMID 35552645

4

Profiling the regulatory interplay of BET bromodomains and Sirtuins in cancer cell lines

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Järvenpää, J. | Rahnasto-Rilla, M. | Lahtela-Kakkonen, M. | +1

5

Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate

enthalten in: Journal of medicinal chemistry | 2022

von Humphreys, P. | Atkinson, S. | Bamborough, P. | +36

6

Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2022

von Fourniols, T. | Maggio, V. | Rafael, D. | +7

7

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2022

von Principe, D. | Xiong, R. | Li, Y. | +14

8

Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor

enthalten in: European journal of medicinal chemistry | 2022

von Hu, R. | Wang, W. | Yang, Y. | +6

9

Mechanistic Insights into the Selective Dual BET and PLK1 Inhibitory Activity of a Novel Benzamide Compound in Castration-Resistant Prostrate Cancer

enthalten in: Chemistry & biodiversity | 2021

von Akawa, O. | Subair, T. | Omolabi, K. | +2

10

Progress in the development of domain selective inhibitors of the bromo and extra terminal domain family (BET) proteins

enthalten in: European journal of medicinal chemistry | 2021

von Fu, Y. | Zhang, Y. | Sun, H.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]